Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Madison, Wisconsin 53792


The purpose of this research is to determine the effectiveness of CGC-11047 in subjects with metastatic hormone refractory prostate cancer as measured by changes in PSA.


Inclusion Criteria: - Metastatic hormone refractory prostate cancer. - Eastern Cooperative Oncology Group (ECOG) Performance status of 0-1. - testosterone <50ng/dL. Patients must continue primary androgen deprivation with an LHRH analogue if they have not undergone orchiectomy. - Progressive disease after androgen deprivation. Exclusion Criteria: - Patients whose clinical condition would make chemotherapy clearly indicated. - Patients who have received systemic chemotherapy for the treatment of metastatic disease. - Peripheral neuropathy > Grade 1 - Prior anti-angiogenic therapy, including thalidomide. - Patients with inadequate recovery from any prior surgical procedure, or patients having undergone any major surgical procedure or radiation within 4 weeks prior to study entry. - Patients who have received radiopharmaceuticals (strontium, samarium) within 8 weeks prior to enrollment. - Patients with known brain metastases or history of brain metastases. - History of stroke within 6 months of treatment or other significant neurological limitations. - Patients who have received more than 2 prior investigational treatments. - Uncontrolled intercurrent illness - Patients with a history of a myocardial infarction within the prior 6 months or, hospitalizations for decompensated congestive heart failure within the prior 6 months, or history of significant / symptomatic cardiac arrhythmias



Primary Contact:


Backup Contact:


Location Contact:

Madison, Wisconsin 53792
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.